These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7925900)
21. Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up. Lambin P; Lefrere JJ; Doinel C; Fine JM; Salmon D; Salmon C Clin Chem; 1988 Jun; 34(6):1367-8. PubMed ID: 3288377 [No Abstract] [Full Text] [Related]
22. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy. Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095 [TBL] [Abstract][Full Text] [Related]
23. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection. Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120 [TBL] [Abstract][Full Text] [Related]
24. A prospective study of the association of serum neopterin, beta 2-microglobulin, and hepatitis B surface antigenemia with death in infants and children with HIV-1 disease. Di Franco MJ; Zaknun D; Zaknun J; Vuja E; Oswald HP; Mayersbach P; Hunter D; Tosteson TD; Trichopoulos D; Schmitzberger R J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1079-85. PubMed ID: 8083826 [TBL] [Abstract][Full Text] [Related]
25. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199 [TBL] [Abstract][Full Text] [Related]
26. [HIV-1 antigenemia and T-cell activation in HIV-1 infected patients]. Harrer T; Wolf B; Kersten W; Schwarz W; Bergner D; Kalden JR Klin Wochenschr; 1990 Sep; 68(17):864-8. PubMed ID: 2214610 [TBL] [Abstract][Full Text] [Related]
27. Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection. Bogner JR; Junge-Hülsing B; Kronawitter U; Sadri I; Matuschke A; Goebel FD Clin Investig; 1992 Aug; 70(8):665-9. PubMed ID: 1392442 [TBL] [Abstract][Full Text] [Related]
28. Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Boldt MJ; Bai TR Chest; 1997 May; 111(5):1187-92. PubMed ID: 9149568 [TBL] [Abstract][Full Text] [Related]
29. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients]. Armbruster C; Hassl A; Kriwanek S Wien Klin Wochenschr; 1998 Sep; 110(17):604-7. PubMed ID: 9816629 [TBL] [Abstract][Full Text] [Related]
31. Neopterin and beta 2-microglobulin and the assessment of intra-blood-brain-barrier synthesis of HIV-specific and total IgG. Peter JB; McKeown KL; Barka NE; Tourtellotte WW; Singer EJ; Syndulko K J Clin Lab Anal; 1991; 5(5):317-20. PubMed ID: 1941351 [TBL] [Abstract][Full Text] [Related]
32. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W; Jaruga B; Pawłowska M Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343 [TBL] [Abstract][Full Text] [Related]
33. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535 [TBL] [Abstract][Full Text] [Related]
34. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha. Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671 [TBL] [Abstract][Full Text] [Related]
35. Early markers of HIV infection and subclinical disease progression. Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175 [TBL] [Abstract][Full Text] [Related]
36. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of serum beta 2-microglobulin in HIV infection. Krämer A; Goedert JJ; Wachter H; Fuchs D Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663 [No Abstract] [Full Text] [Related]
38. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Quist J; Hill AR Chest; 1995 Aug; 108(2):415-8. PubMed ID: 7634877 [TBL] [Abstract][Full Text] [Related]
39. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment]. González-García J; Rubio García R; Antela López A; García Alcaide F Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618 [TBL] [Abstract][Full Text] [Related]
40. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. Samsonov M; Fuchs D; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H Clin Chem; 1992 May; 38(5):678-80. PubMed ID: 1582019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]